Superb Drugs Profile
Key Indicators
- Authorised Capital ₹ 7.50 M
as on 19-12-2024
- Paid Up Capital ₹ 7.25 M
as on 19-12-2024
- Company Age 51 Year, 5 Months
- Last Filing with ROC 31 Mar 2014
- Open Charges ₹ 7.96 Cr
as on 19-12-2024
About Superb Drugs
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2014. It's a company limited by shares with an authorized capital of Rs 7.50 M and a paid-up capital of Rs 7.25 M.
The company currently has active open charges totaling ₹7.96 Cr.
Raj Kanoria, Ajay Baral, and Ram Sah serve as directors at the Company.
- CIN/LLPIN
U70109WB1973PTC010840
- Company No.
010840
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
25 Jun 1973
- Date of AGM
30 Sep 2014
- Date of Balance Sheet
31 Mar 2014
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
Kolkata, West Bengal, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Superb Drugs?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Raj Kanoria  | Director | 14-Jan-2016 | Current |
| Ajay Baral | Director | 03-Nov-2014 | Current |
| Ram Sah | Director | Current |
Financial Performance and Corporate Structure Insights of Superb Drugs.
Enhance accessibility to Superb Drugs's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Superb Drugs?
Unlock access to Superb Drugs's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Idbi Bank Ltd. Creation Date: 26 Aug 2009 | ₹4.75 Cr | Open |
United Bank Of India Creation Date: 24 Apr 2004 | ₹2.86 Cr | Open |
United Bank Of India Creation Date: 28 May 2002 | ₹3.50 M | Open |
How Many Employees Work at Superb Drugs?
Superb Drugs has a workforce of 0 employees as of Mar 21, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Superb Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Superb Drugs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
